Log in or Sign up for Free to view tailored content for your specialty!
Ophthalmic Business News
Alcon, J&J Surgical Vision resolve femtosecond laser litigation
Alcon has entered into a settlement agreement with J&J Surgical Vision to resolve legal proceedings related to femtosecond laser-assisted cataract surgery devices, according to a company press release.
FDA accepts NDA for Nyxol drops for mydriasis reversal
The FDA accepted a new drug application for Nyxol for the reversal of pharmacologically induced mydriasis, according to a press release from Ocuphire Pharma.
Log in or Sign up for Free to view tailored content for your specialty!
Practice’s retirement can create liability: Four common pitfalls to avoid
Most medical practices nationwide sponsor some type of qualified retirement plan (QRP), including 401(k)s, profit-sharing plans, defined benefit plans and hybrid plans. Most physicians do not realize that a growing area of liability for all businesses, including medical practices, relates to QRPs and how they are managed.
FDA grants fast track designation for retinitis pigmentosa treatment
EA-2353 for the treatment of retinitis pigmentosa received fast track designation from the FDA, according to a press release from Endogena Therapeutics.
BLOG: Exiting, slowly, stage left: Novartis sheds more minor drugs
How were your holidays? This is kinda old news to be honest, seeing as how it was announced in a press release by the acquiring company just before Christmas.
BLOG: Noncompete agreements are not a thing of the past yet
There has been a lot of attention about a proposed rule from the Federal Trade Commission that would prohibit many noncompetes. However, much of the discussion has been misleading, if not entirely wrong.
EyeArt AI system approved in EU for detecting AMD, glaucomatous optic nerve damage
The EyeArt AI eye screening system has been approved for marketing in the European Union for detecting age-related macular degeneration and glaucomatous optic nerve damage, according to a press release from Eyenuk.
Harrow obtains J-code for ocular surface anesthesia gel
CMS issued a permanent, product-specific J-code for Iheezo, an ocular surface anesthesia gel, according to a Harrow press release.
VIDEO: Johnson & Johnson Vision shares data at Hawaiian Eye
KOLOA, Hawaii — In this Healio Video Perspective, Rajesh K. Rajpal, MD, chief medical officer for Johnson & Johnson Vision, discusses the opportunities the company has for learning and sharing information at Hawaiian Eye 2023.
FDA approves ML6710i photodynamic laser for use with Visudyne
The FDA has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s Visudyne photodynamic therapy for the treatment of classic subfoveal choroidal neovascularization due to age-related macular degeneration.